Haplotypes of tumor necrosis factor gene and tracheal aspirate fluid levels of tumor necrosis factor-α in preterm infants

Pediatric Research

Volumn 64, Issue 2, 2008, Pages 165-170

  Kazzi, S Nadya J ^a,d   Tromp, Gerard ^a   Quasney, Michael W ^b   Buhimschi, Irina A ^c  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Hutzel Womens Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LYMPHOTOXIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CHORIOAMNIONITIS; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HUMAN; INFANT; LUNG DYSPLASIA; MAJOR CLINICAL STUDY; MALE; PREMATURITY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; TRACHEAL ASPIRATION PROCEDURE; GENE FREQUENCY; GENETICS; METABOLISM; NEWBORN; PREGNANCY; SUCTION; TRACHEA;

BRONCHOPULMONARY DYSPLASIA; CHORIOAMNIONITIS; FEMALE; GENE FREQUENCY; GENOTYPE; HAPLOTYPES; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; MALE; PREGNANCY; RISK FACTORS; SUCTION; TRACHEA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 52649171474     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1203/PDR.0b013e31817758f4     Document Type: Article

References (32)

1. Speer CP, Groneck P 2000 Inflammatory mediators in neonatal lung disease. In: Bland R, Coalson J (eds) Chronic Lung Disease in Early Infancy. New York: Marcel Dekker, pp 147-157
2. Jónsson B, Tullus K, Brauner A, Lu Y, Noack G 1997 Early increase of TNF-a and IL-6 in tracheobronchial aspirate fluid indicator of subsequent chronic lung disease in preterm infants. Arch Dis Child Fetal Neonatal Ed 77:F198-F201
3. Eigler A, Sinha B, Hartmann G, Endres S 1997 Taming TNF: strategies to restrain this proinflammatory cytokine. Immunol Today 18:487-492
4. de Dooy JJ, Mahieu LM, van Bever HP 2001 The role of inflammation in the development of chronic lung disease in neonates. Eur J Pediatr 160:457-463
5. Kelly M, Kolb M, Bonniaud P, Gauldie J 2003 Re-evaluation of fibrogenic cytokines in lung fibrosis. Curr Pharm Des 9:39-49
6. Molvig J, Baek L, Christensen P, Manogue KR, Vlassara H, Platz P, Nielsen LS, Svejgaard A, Nerup J 1988 Endotoxin-stimulated human monocyte secretion of interleukin 1, tumor necrosis factor alpha, and prostaglandin E2 shows stable interindividual differences. Scand J Immunol 27:705-716
7. Westendorp RG, Langermans JM, Huizinga TW, Elouali AH, Verweij CL, Boomsma DI, Vandenbroucke JP 1997 Genetic influence on cytokine production and fatal meningococcal disease. Lancet 349:170-173
8. Sariban E, Imamura K, Luebbers R, Kufe D 1988 Transcriptional and posttranscrip- tional regulation of tumor necrosis factor gene expression in human monocytes. J Clin Invest 81:1506-1510
9. Goldfeld AE, Strominger JL, Doyle C 1991 Human tumor necrosis factor alpha gene regulation in phorbol ester stimulated T and B cell lines. J Exp Med 174:73-81
10. Kroeger KM, Carville KS, Abraham LJ 1997 The -308 tumor necrosis factor-a promoter polymorphism effects transcription. Mol Immunol 34:391-399
11. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW 1997 Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci USA 94:3195-3199
12. Mc Arthur JA, Zhang Q, Quasney MW 2002 Association between the A/A genotype at the lymphotoxin-alpha+250 site and increased mortality in children with positive blood cultures. Pediatr Crit Care Med 3:341-344
13. Kaluza W, Reuss E, Grossmann S, Hug R, Schopt RE, Galle PR, Maerker-Hermann E, Hoehler T 2000 Different transcriptional activity and in vitro TNF-α production in psoriasis patients carrying the TNF-α-238 A promoter polymorphism. J Invest Dermatol 114:1180-1183
14. Day CP, Grove J, Daly AK, StewartMW, Avery PJ, WalkerM 1998 Tumornecrosis factor-alpha gene promoter polymorphism and decreased insulin resistance. Diabetologia 41:430-434
15. Quasney MW, Bronstein DE, Cantor RM, Zhang Q, Stroope C, Shike H, Bastian JF, Matsubara T, Fujiwara M, Akimoto K, Newburger JW, Burns JC 2001 Increased frequency of alleles associated with elevated tumor necrosis factor-a levels in children with Kawasaki disease. Pediatr Res 49:686-690
16. Ballard JL, Khoury JC, Wedig K, Wang L, Eilers-Walsman BL, Lipp R 1991 New Ballard Score, expanded to include extremely premature infants. J Pediatr 119:417-423
17. Kazzi SN, Jacques SM, Qureshi F, Quasney MW, Kim OU, Buhimschi IA 2004 Tumor necrosis factor-a+250 is associated with the presence and severity of placental inflammation among preterm births. Pediatr Res 56:94-98
18. R Development Core Team 2006 R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing
19. Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA 2002 Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 70:425-434
20. Schaid DJ 2004 Evaluating associations of haplotypes with traits. Genet Epidemiol 27:348-364
21. Hajeer AH, Hutchinson IV 2001 Influence of TNFa gene polymorphisms on TNFa production and disease. Hum Immunol 62:1191-1199
22. Baxter N, Sumiya M, Cheng S, Erlich H, Regan A, Simons A, Summerfield JA 2001 Recurrent miscarriage and variant alleles of mannose binding lectin, tumour necrosis factor and lymphotoxin α genes. Clin Exp Immunol 126:529-534
23. Gordon AC, Lagan AL, Aganna E, Cheung L, Peters CJ, McDermott MF, Welsh KI, Holloway P, Hitman GA, Piper RD, Garrard CS, Hinds CJ 2004 TNF and TNFR polymorphisms in severe sepsis and septic shock: a prospective multicentre study. Genes Immun 5:631-640
24. Sato H, Silveira L, Fingerlin T, Dockstader K, Gillespie M, Lagan AL, Lympany P, Sawyer RT, duBois RM, Welsh KI, Maier LA 2007 TNF polymorphism and bronchoalveolar lavage cell TNF-α levels in chronic beryllium disease and beryllium sensitization. J Allergy Clin Immunol 119:687-696
25. Bouma G, Crusius JB, Oudkerk Pool M, Kolkman JJ, von Blomberg BM, Kostense PJ, Giphart MJ, Schreuder GM, Meuwissen SG, Pena AS 1996 Secretion of tumour necrosis factor alpha and lymphotoxin alpha in relation to polymorphism in the TNF genes and HLA-DR alleles. Relevance for inflammatory bowel disease. Scand J Immunol 43:456-463
26. Shirts BH, Bamne M, Kim JJ, Talkowski M, Wood J, Yolken R, Mimgaonkar VL 2006 A comprehensive genetic association and functional study of TNF in schizophrenia risk. Schizophr Res 83:7-13
27. Sharma S, Sharma A, Kumar S, Sharma SK, Ghosh B 2006 Association of TNF haplotypes with asthma, serum IgE levels and correlation with serum TNF-α levels. Am J Respir Cell Mol Biol 35:488 -495
28. Warzocha K, Ribeiro P, Bienvenu J, Roy P, Charlot C, Rigal D, Coiffier B, Salles G 1998 Genetic polymorphisms in the tumor necrosis factor locus influence non- Hodgkin's lymphoma outcome. Blood 91:3574-3581
29. Bilolikar H, Nam AR, Rosenthal M, Davies JC, Henderson DC, Balfour-Lynn IM 2005 Tumor necrosis factor gene polymorphisms and childhood wheezing. Eur Respir J 26:637-646
30. Jobe AH, Bancalari E 2001 Bronchopulmonary dysplasia. Am J Respir Crit Care Med 163:1723-1729
31. Kazzi SN, Kim O, Quasney MW, Buhimschi I 2004 Polymorphism of tumor necrosis factor-a and risk and severity of bronchopulmonary dysplasia among very low birth weight infants. Pediatrics 114:e243-e248
32. Dø Vatten L, Halgunset J, Rahimipoor S, Austgulen R 2002 Histologic chorioamnionitis and umbilical serum levels of pro-inflammatory cytokines and ytokine inhibitors. BJOG 109:534-539